Prix
GRAPH PAR
Questions fréquentes
Quelle est la capitalisation boursière de Grifols ?
Quel est le ratio cours/bénéfice (P/E) de Grifols ?
Quel est le bénéfice par action (BPA) de Grifols ?
Quelles sont les évaluations des analystes et le prix cible de l'action Grifols ?
Quel est le chiffre d'affaires de Grifols sur les douze derniers mois ?
Quel est l'EBITDA de Grifols ?
Combien d'employés compte Grifols, et à quel secteur d'activité appartient-elle ?
Quel est le flottant des actions de Grifols ?
Finances
- Capitalisation boursière
- 6,55 Md $US
- BPA (TTM)
- 0,24 $US
- Free Float
- 291,12 M
- Ratio P/E (TTM)
- 106,16
- Recettes (TTM)
- 6,83 Md $US
- EBITDA (TTM)
- 1,35 Md $US
Cotation
- 1D span
- 9,478 $US9,817 $US
- 52W span
- 6,908 $US17,61 $US
Notes des analystes
L'objectif de prix est de 16,27 $US et l'action est analysée par 14 analystes.
Acheter
10
Hold
3
Vendre
1
Informations
Grifols SA engages in the production of plasma derivatives. It operates through the following segments: Bioscience, Hospital, Diagnostic, Bio Supplies, and Others. The Bioscience Segment includes all activities related with products deriving from human plasma for therapeutic use. The Hospital Segment comprises of all non-biological pharmaceutical products and medical supplies manufactured by group companies earmarked for hospital pharmacy. The Diagnostic Segment deals with the marketing of diagnostic testing equipment, reagents, and other equipment. The Bio Supplies segment consists of all transactions related to biological products for non-therapeutic use. The Others segment focuses on the rendering of manufacturing services to third party companies. The company was founded by José Antonio Grifols Roig on November 18, 1940 and is headquartered in Barcelona, Spain.
- Salariés
- 23 744
- Industries
- Pharmaceuticals: Major
- Secteur
- Soins de santé
Identifiant
- ISIN
- ES0171996087
- Ticker primaire
- GRF